Sat Kartar Life Ltd vs Sun Pharma.Inds.
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Sat Kartar Life Ltd currently has the stronger revenue growth signal.
Sat Kartar Life Ltd show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Sat Kartar Life Ltd | Sun Pharma.Inds. |
|---|---|---|
| Current Price | ₹130.45 | ₹1,748 |
| Market Cap | ₹206.49 Cr. | ₹4.19 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 12.97 | 33.21 |
| ROE (%) | 26.74 | 15.95 |
| Debt/Equity | 0.04 | 0.06 |
| Sales Growth 5Y (%) | — | 11.78 |
| Profit Growth 5Y (%) | -32.08 | 5.62 |
| Promoter Holding (%) | 63.62 | 52.68 |
| Revenue Rank | Rank 2 | Rank 3 |
| Margin Rank | Rank 1 | Rank 3 |
| Signal | — | — |
| Capex | Yes | No information |
| Fundraise | No information | No information |